PLoS ONE (Jan 2013)

Brap2 regulates temporal control of NF-κB localization mediated by inflammatory response.

  • Osamu Takashima,
  • Fuminori Tsuruta,
  • Yu Kigoshi,
  • Shingo Nakamura,
  • Jaehyun Kim,
  • Megumi C Katoh,
  • Tomomi Fukuda,
  • Kenji Irie,
  • Tomoki Chiba

DOI
https://doi.org/10.1371/journal.pone.0058911
Journal volume & issue
Vol. 8, no. 3
p. e58911

Abstract

Read online

Nuclear factor-kappaB (NF-κB) is critical for the expression of multiple genes involved in inflammatory responses and cellular survival. NF-κB is normally sequestered in the cytoplasm through interaction with an inhibitor of NF-κB (IκB), but inflammatory stimulation induces proteasomal degradation of IκB, followed by NF-κB nuclear translocation. The degradation of IκB is mediated by a SCF (Skp1-Cullin1-F-box protein)-type ubiquitin ligase complex that is post-translationaly modified by a ubiquitin-like molecule Nedd8. In this study, we report that BRCA1-associated protein 2 (Brap2) is a novel Nedd8-binding protein that interacts with SCF complex, and is involved in NF-κB translocation following TNF-α stimulation. We also found a putative neddylation site in Brap2 associated with NF-κB activity. Our findings suggest that Brap2 is a novel modulator that associates with SCF complex and controls TNF-α-induced NF-κB nuclear translocation.